- Home
- ALNY vs CPRT Comparison
ALNY vs CPRT Comparison
Compare ALNY & CPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- CPRT
- Stock Information
- Founded
- ALNY 2002
- CPRT 1982
- Country
- ALNY United States
- CPRT United States
- Employees
- ALNY N/A
- CPRT N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- CPRT Other Specialty Stores
- Sector
- ALNY Health Care
- CPRT Consumer Discretionary
- Exchange
- ALNY Nasdaq
- CPRT Nasdaq
- Market Cap
- ALNY 42.9B
- CPRT 48.5B
- IPO Year
- ALNY 2004
- CPRT 1994
- Fundamental
- Price
- ALNY $339.80
- CPRT $46.28
- Analyst Decision
- ALNY Strong Buy
- CPRT Hold
- Analyst Count
- ALNY 25
- CPRT 3
- Target Price
- ALNY $347.75
- CPRT $53.33
- AVG Volume (30 Days)
- ALNY 878.5K
- CPRT 6.9M
- Earning Date
- ALNY 07-31-2025
- CPRT 09-03-2025
- Dividend Yield
- ALNY N/A
- CPRT N/A
- EPS Growth
- ALNY N/A
- CPRT 5.62
- EPS
- ALNY N/A
- CPRT 1.51
- Revenue
- ALNY $2,348,099,000.00
- CPRT $4,590,860,000.00
- Revenue This Year
- ALNY $32.73
- CPRT $12.66
- Revenue Next Year
- ALNY $31.50
- CPRT $8.38
- P/E Ratio
- ALNY N/A
- CPRT $30.64
- Revenue Growth
- ALNY 17.21
- CPRT 10.21
- 52 Week Low
- ALNY $205.87
- CPRT $45.52
- 52 Week High
- ALNY $345.98
- CPRT $64.38
- Technical
- Relative Strength Index (RSI)
- ALNY 66.90
- CPRT 37.40
- Support Level
- ALNY $323.74
- CPRT $46.02
- Resistance Level
- ALNY $332.19
- CPRT $46.81
- Average True Range (ATR)
- ALNY 8.07
- CPRT 0.76
- MACD
- ALNY 0.53
- CPRT 0.19
- Stochastic Oscillator
- ALNY 83.03
- CPRT 30.89
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About CPRT Copart Inc. (DE)
Based in Dallas, Copart operates an online salvage vehicle auction with operations in 11 countries across North America, Europe, and the Middle East, facilitating over 3.5 million transactions annually. The company utilizes its virtual bidding platform, VB3, to connect vehicle sellers with over 750,000 registered buyers around the world. Buyers primarily consist of vehicle dismantlers, rebuilders, individuals and used vehicle retailers. About 80% of Copart's vehicle volume is supplied by auto insurance companies holding vehicles deemed a total loss. Copart also offers services such as vehicle transportation, storage, title transfer, and salvage value estimation. The company primarily operates on a consignment basis and collects fees based on the vehicle's final selling price.